Frontlight ResearchEarly access
Research view
Switch to patient viewMyeloproliferative neoplasms: trials that stopped early
Trials on Myeloproliferative neoplasms that stopped early, each with the reason the sponsor wrote in the registry, quoted word for word. Next to them: finished trials whose registry record links a result paper.
Stopped early
31 stopped trials give a reason in the registry, latest registry update first.
Withdrawn
Study of Select Combinations in Adults With Myelofibrosis
Reason given in the registry “This study was cancelled before enrolling any patients for business related reasons.”
Quoted unchanged from ClinicalTrials.gov; record updated 4 Mar 2021.
- Ended
- Apr 2024
- Phase
- Phase 1
- Run by
- Novartis Pharmaceuticals
- Registry record
- NCT04283526
Sources: ClinicalTrials.gov and the EU Clinical Trials Register. Status, reason, dates and result links are registry fields, shown as the registry gives them.